LogMAR Visual Acuity
Primary
· 4 hours
High contrast/high illumination distant (6M) logMAR vision
| Group | Value | 95% CI |
|---|---|---|
| Presbyopia | -0.07 | ± 0.07 |
Last reviewed · How we verify
NCT05495971
Extended Depth of Focus Contact Lenses for Presbyopia
Completed
NA
Results posted
Last updated 16 December 2024
What this trial tests
NA trial testing NaturalVue Multifocal in Presbyopia in 24 participants. Completed in 12 May 2023.
Timeline
6 September 2022
Primary endpoint
12 May 2023
12 May 2023
12 May 2023
Quick facts
| Lead sponsor | Visioneering Technologies, Inc |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 6 September 2022 |
| Primary completion | 12 May 2023 |
| Estimated completion | 12 May 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- NaturalVue Multifocal
Conditions studied
- Presbyopia — all drugs for Presbyopia →
Sponsor
Visioneering Technologies, Inc
Who can join
Adults 45 to 70, any sex, with Presbyopia. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Sponsor's own description
VTI has an FDA cleared soft contact lens product. Its optical design creates an enhanced depth of focus (EDOF), which provides clear distance, intermediate, and near vision. This study is to quantify the enhanced depth of focus and visual impact.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluation of the Functional Visual Range of a Catenary Curve-Based, Extended Depth-of-Focus Contact Lens for Presbyopia.
Tuan KA, Benoit DP, O'Connor B. · · 2024 · cited 2× · PMID 39055378 · DOI 10.2147/opth.s468699
Verify or expand the search:
- PubMed search for NCT05495971
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Presbyopia
Currently open trials in the same condition.
- NCT07444658 — Performance of Two Daily Disposable Multifocal Contact Lenses · NA · recruiting
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07077967 — Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs · recruiting
- NCT07113210 — Quality of Life in Presbyopic Patients Who Are Treated With Qlosi · Phase 4 · recruiting
- NCT06948357 — Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients · Phase 2 · recruiting
Other Visioneering Technologies, Inc trials
Trials by the same sponsor.
- NCT06475053 — Visual Performance of Center Distance Daily Disposable Multifocal Lenses · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
Data sources for this page
- Trial protocol + status: ClinicalTrials.gov NCT05495971 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Visioneering Technologies, Inc
- Last refreshed: 16 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05495971.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing